On the contrary, other studies concluded that increased irisin levels mediate cardioprotection in diabetic subjects and inhibit myocardial apoptosis, implicating irisin as a potential therapeutic intervention during diabetic cardiomyopathy [44,45,46]. This evidence concerns the gene FNDC5 and diabetic cardiomyopathy.